Eric J. Hyllengren, EVP, CFO at Atara Biotherapeutics, Inc. (ATRA), sold 1,070 shares at $6.63 ($7K) on 2024-08-16, disclosed to the SEC on 2024-08-20.
Open-market sale of $7k ATRA by EVP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.63 | 29 | $192 | 2.7% |
| 2 | $6.63 | 1,041 | $7K | 97.3% |
| Total | $6.63 avg | 1,070 | $7K | 100% |
| Filing → |
| ATRA | SELL | 2024-05-20 | $18K | — | Filing → |
| ATRA | SELL | 2024-03-06 | $5K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $5K | — | Filing → |